Taken together, our findings support the notion that TRAIL and RIPK3 do not act as independent predictors of AKI or mortality, but rather as components of a broader network of pathways influenced by underlying cardiovascular and renal dysfunction. This evidence concerns the gene RIPK3 and acute kidney injury.